Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

7.8K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.8K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

5.7K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

8.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.0K
Muscles of the Eye01:20

Muscles of the Eye

4.5K
The muscles of the eye are sophisticated structures that control eye movement and focus, allowing for the precise and rapid adjustments necessary for vision. The human eye is controlled by ten muscles — six extraocular muscles, three intraocular muscles, and one primary eyelid retractor muscle.
Extraocular Muscles
The six extraocular muscles surround the eyeball and control its movements. They are responsible for a wide range of eye motions, including looking up, down, left, right, and...
4.5K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative Orbital Compliance as a Predictor for Outcomes of Fat Decompression in Thyroid Eye Disease.

Ophthalmic plastic and reconstructive surgery·2026
Same author

The Use of Deep Learning in Distinguishing Chalazion and Eyelid Mass.

Journal of ophthalmology·2026
Same author

Transorbital Approach to Surgical Resection of a Far-Lateral Frontal Sinus Osteoma.

Journal of neurological surgery reports·2026
Same author

Endoscopic Transorbital Approach for Select Recurrent and Newly Diagnosed Anteromedial Temporal Lobe Gliomas.

Journal of neurological surgery. Part B, Skull base·2026
Same author

Relapse Versus Rebound in Thyroid Eye Disease After Teprotumumab Treatment: A Retrospective Case Series.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Primary Periorbital Extra-skeletal Osteoma: A Novel Clinical Entity.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Orbital Inflammatory Syndrome Associated with Bispecific T-Cell Engager Therapy: Case and Literature Review.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

A Rare Pedunculated Lobular Capillary Hemangioma of the Conjunctiva.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Core Oculoplastic Procedure Skills for the Comprehensive Ophthalmologist: A Consensus by Delphi Methodology.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

The Role of Corneal Sensation in Facial Nerve Paralysis.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Lacrimal Gland Dacryolithiasis With Secondary Bacterial Dacryoadenitis: Clinicoradiological Characterization and Review of Literature.

Ophthalmic plastic and reconstructive surgery·2026
Same journal

Aprepitant for Oculoplastic Surgeries.

Ophthalmic plastic and reconstructive surgery·2026
See all related articles

Related Experiment Video

Updated: Feb 10, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.5K

Radiotherapy for Active Thyroid Eye Disease.

Kyle J Godfrey1, Michael Kazim

  • 1Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons, New York, New York, U.S.A.

Ophthalmic Plastic and Reconstructive Surgery
|May 18, 2018
PubMed
Summary
This summary is machine-generated.

Orbital radiotherapy (ORT) is a safe and effective treatment for active thyroid eye disease (TED). It is best suited for patients with moderate to severe, active TED, often alongside corticosteroids.

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.5K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.3K

Related Experiment Videos

Last Updated: Feb 10, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.5K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.5K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.3K

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Radiation Oncology

Background:

  • Thyroid eye disease (TED) is an autoimmune condition affecting the orbits.
  • Current treatments aim to modulate the immune response and manage symptoms.
  • Orbital radiotherapy (ORT) is a potential therapeutic option for active TED.

Purpose of the Study:

  • To critically review the published literature on orbital radiotherapy (ORT) for thyroid eye disease (TED).
  • To identify optimal patient selection criteria and treatment parameters for ORT in TED.

Main Methods:

  • A systematic review and analysis of relevant published literature was performed.
  • Literature search focused on studies evaluating ORT for thyroid eye disease.

Main Results:

  • ORT is most beneficial for patients in the early, active phase of TED with moderate to severe or rapidly progressive disease.
  • Ideal candidates include those with motility deficits, compressive optic neuropathy, or progressive strabismus.
  • ORT may reduce the need for urgent surgical decompression in compressive optic neuropathy.
  • ORT is generally recommended in conjunction with corticosteroid therapy.
  • Standard ORT doses approach 20 Gy, with lower doses considered for specific patient groups.
  • Side effects are minimal in appropriately selected patients.

Conclusions:

  • Orbital radiotherapy is a safe and effective treatment for active TED in appropriately selected patients.
  • Careful patient selection is crucial for optimizing outcomes and minimizing risks associated with ORT.